Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > How high on the OTC?
View:
Post by Camphikefish on Oct 21, 2024 5:33pm

How high on the OTC?

Hi everyone, for planning purposes, (you all know way better than I do) how high can this realistically travel north on the OTC exchange? Could it truly see $10 here or would the stock need to be on the Nasdaq to get there? Yes, it's one of this questions I'm embarrassed to ask but it would be great to know what you folks think. You can have all of mine for 10! 

Thank you one and all!

Comment by enriquesuave on Oct 21, 2024 5:46pm
There are $100 dollar stocks on OTC.  Market has to see potential is near and SP will move.  It's starting to move it seems.  We don't need to be on Nasdaq.  It's better, but not necessary for SP to move once we have the goods.  iMHO  
Comment by chry200030 on Oct 21, 2024 5:50pm
A lot more than $10.
Comment by Legit62 on Oct 21, 2024 5:57pm
I honestly wouldnt be giving this stock away for $10 unless we get a bought out for $10, this could roll, but the nasdaq a much better exchange to be on, it is a more legit exchange with strict financial and liquidity requirements than the OTC or canadian Venture. But that is not to say TLTFF cant become a huge hit on the OTC, but Rogers stated goal is to get this to the nasdaq or better exchange
Comment by TommyNickels on Oct 21, 2024 6:43pm
This has the ability to meme. And it's based on upcoming FDA news. The cure for cancer. This gets to reddit and watch out. Ask yourself what is Theralase worth if they sign a JV, get government funding and get BTD approval?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250